Medical Market Intelligence
Our team are dedicated to different therapy areas, allowing them to develop a broad working knowledge and awareness of current trends.
In 2024, the team delivered 31 projects in 14 markets, collecting the evidence base to make informed decisions in the following areas:
Thoraco-abdominal endovascular devices
Left Ventricular Assist Devices
Peripheral vascular disease
Venous stent
Above-The-Knee interventions
Below-The-Knee interventions
Intravascular lithotripsy
Dialysis access creation and revision
Left atrial appendage occluders
Liquid embolic agents
Liver interventions
Endoscopic and endovascular TIPS
TICE (Transarterial Intrahepatic Chemoembolization Evaluation)
Surgical closure devices
Surgical accessories
Hemostasis devices
Cystoscopy
Tumour ablation
Oncology pancreatic and breast
Immunotherapy
KRAS inhibitors
Antibody-drug conjugates
Hemophilia and inhibitors
Urology endoscopy imaging and access
Example of communications campaign developed for GORE Medical.
Across the team we have over 50 years experience in medical research in different settings from academia, public health and business consulting.
In the past, we’ve worked across vaccines, pharmaceutical and international public health.
Projects delivered in 2024, include:
Market Opportunity Japan: Cirrhosis
Product Positioning: Thoraco-abdominal Endovascular Device
Market Landscape: Anti-rejection drugs
Patient Experience: Clinical Trial Support Dialysis Access Graft US Market
Patient Experiences: Haemophilia and Inhibitors
Market Opportunities: Dialysis Access - US, EU, MENA, LATAM
Communications Development: Post MI patients
Market Opportunities: Acute Myeloid Leukemia
Market Opportunities - MENA: Tumor Ablation
Tracking Uptake: Bladder Cancer Drug
Pricing Survey: Guidewires - EU and US Markets
Market Landscape: Intravascular Lithotripsy EU and US Markets
Communications: Dialysis Graft Product Portfolio Messaging
Patient Experiences: Left Ventricular Assist Devices
